Post Hoc Subgroup Analysis Response

被引：0
|
作者：
Hung, Ivan F. N. [1 ,2 ,3 ]
Yuen, Kwok-Yung [2 ,3 ]
机构：
[1] Univ Hong Kong, Queen Mary Hosp, Dept Med, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Queen Mary Hosp, Carol Yu Ctr Infect, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China
[3] Univ Hong Kong, Queen Mary Hosp, Div Infect Dis, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China
来源：
CHEST | 2014年 / 145卷 / 02期
关键词：
D O I：
10.1378/chest.13-2617
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：435 / 435
页数：1
相关论文
共 50 条
  • [31] Characteristics of post hoc subgroup analyses of oncology clinical trials: a systematic review
    Alrawabdeh, Jawad
    Alzu'bi, Marah
    Alzyoud, Muntaser
    Odeh, Nada
    Hamadneh, Yazan
    Mian, Hira
    Mohyuddin, Ghulam Rehman
    Kelkar, Amar H.
    Goodman, Aaron M.
    Chakraborty, Rajshekhar
    Russler-Germain, David A.
    Mehra, Nikita
    Baggio, Diva
    Cliff, Edward R. Scheffer
    Al Hadidi, Samer
    JNCI CANCER SPECTRUM, 2023, 7 (06)
  • [32] A Systematic Approach for Post Hoc Subgroup Analyses With Applications in Clinical Case Studies
    Muysers, Christoph
    Dmitrienko, Alex
    Kulmann, Hermann
    Kirsch, Bodo
    Lippert, Susanne
    Schmelter, Thomas
    Schulz, Anke
    Mentenich, Nicole
    Schmitz, Heinz
    Schaefers, Matthias
    Meinhardt, Gerold
    Keil, Thomas
    Roll, Stephanie
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (03) : 507 - 518
  • [33] Efficacy Response in CF Patients Treated With Ivacaftor: Post-Hoc Analysis
    Konstan, Michael W.
    Plant, Barry J.
    Elborn, J. Stuart
    Rodriguez, Sally
    Munck, Anne
    Ahrens, Richard
    Johnson, Charles
    PEDIATRIC PULMONOLOGY, 2015, 50 (05) : 447 - 455
  • [34] Audience response technology: under-appreciated value of post hoc analysis
    Schick, Paul
    Abramson, Sandra
    Burke, James
    MEDICAL EDUCATION, 2011, 45 (11) : 1157 - 1158
  • [35] Efficacy of ubrogepant based on prior exposure and response to triptans: A post hoc analysis
    Blumenfeld, Andrew M.
    Goadsby, Peter J.
    Dodick, David W.
    Hutchinson, Susan
    Liu, Chengcheng
    Finnegan, Michelle
    Trugman, Joel M.
    Szegedi, Armin
    HEADACHE, 2021, 61 (03): : 422 - 429
  • [36] Is Blood Eosinophil Count a Predictor of Response to Bronchodilators in Chronic Obstructive Pulmonary Disease? Results from Post Hoc Subgroup Analyses
    Ahmar Iqbal
    Neil C. Barnes
    Jean Brooks
    Clinical Drug Investigation, 2015, 35 : 685 - 688
  • [37] Is Blood Eosinophil Count a Predictor of Response to Bronchodilators in Chronic Obstructive Pulmonary Disease? Results from Post Hoc Subgroup Analyses
    Iqbal, Ahmar
    Barnes, Neil C.
    Brooks, Jean
    CLINICAL DRUG INVESTIGATION, 2015, 35 (10) : 685 - 688
  • [38] A Response to Some Criticisms of Post Hoc Power
    Carle, Adam C.
    JOURNAL OF SURGICAL RESEARCH, 2021, 259 : A7 - A8
  • [39] Aspirin Is Beneficial in Hypertensive Patients With Chronic Kidney Disease A Post-Hoc Subgroup Analysis of a Randomized Controlled Trial
    Jardine, Meg J.
    Ninomiya, Toshiharu
    Perkovic, Vlado
    Cass, Alan
    Turnbull, Fiona
    Gallagher, Martin P.
    Zoungas, Sophia
    Lambers Heerspink, Hiddo J.
    Chalmers, John
    Zanchetti, Alberto
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (12) : 956 - 965
  • [40] Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial
    Donald P. Tashkin
    Marc Miravitlles
    Bartolomé R. Celli
    Norbert Metzdorf
    Achim Mueller
    David M. G. Halpin
    Antonio Anzueto
    Respiratory Research, 19
12345